Perceived Effects of Hormone Treatment (HRT) on ADHD Symptoms in Perimenopausal and Menopausal Women: A Cross-Sectional Survey
This cross-sectional survey of 453 women suggests that perceived improvements in ADHD symptoms during perimenopause and menopause vary by hormone treatment type, with transdermal oestrogen and testosterone showing the highest association with symptom relief, though causal conclusions require further prospective research.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For many women, the years leading up to and following the end of menstruation bring a familiar set of challenges: hot flashes, sleepless nights, and a foggy sense of mind that makes focusing difficult. For some, this mental fog feels like a return of a condition they have lived with since childhood, or perhaps the sudden emergence of one they never knew they had. This condition is attention-deficit/hyperactivity disorder, or ADHD, a state where the brain struggles to manage attention, control impulses, and regulate emotions. While doctors have long understood that hormones like estrogen and testosterone play a role in how the brain processes information, the specific link between these hormones and ADHD symptoms during midlife has remained a mystery. Women often report that their ability to concentrate worsens as they approach menopause, yet there is little clear evidence on whether hormone treatments, which are commonly prescribed to ease physical symptoms, might also help clear the mental haze.
A recent survey sought to fill this gap by listening directly to the experiences of hundreds of women navigating this transition. The researchers gathered data from 453 women who were already using hormone treatments for perimenopause or menopause and who had noticed changes in their ADHD-related symptoms. The study did not test new drugs or assign treatments; instead, it asked these women to look back and report whether their symptoms had improved, worsened, or stayed the same after starting different types of hormone therapy. The survey covered five specific areas of difficulty: trouble paying attention, feeling restless or hyperactive, acting without thinking, struggling to manage emotions, and feeling overly sensitive to criticism or rejection. By comparing the reports of women using different hormone formulations, the researchers aimed to see if certain treatments were more likely to be associated with feeling better.
The results painted a clear picture of how different treatments were perceived to work. Women who used estrogen delivered through the skin, such as patches, gels, or sprays, reported the highest likelihood of seeing improvements across all five symptom areas. Similarly, those who added testosterone gel or cream to their regimen also reported very high rates of improvement. In contrast, women using treatments containing progesterone, either as an oral pill or a device placed inside the uterus, reported lower and more mixed results. While some women on progesterone felt better, the likelihood of improvement was generally lower and varied more widely than with the estrogen or testosterone options. The study found that these patterns held true whether the women had a formal medical diagnosis of ADHD or were simply suspecting they had the condition.
One of the most striking findings was how quickly some women felt a difference. A significant portion of the participants noticed improvements in their symptoms within just one to four weeks of starting their hormone treatment. This rapid response suggests that for some, the link between hormonal balance and mental clarity is direct and immediate, rather than something that takes months to develop. The researchers also investigated whether the age at which a woman first struggled with these symptoms mattered. They found that it did not; women whose symptoms had been a problem since childhood reported similar rates of improvement to those whose symptoms only became difficult during their menopausal transition. This suggests that the hormonal changes of midlife might be unmasking or worsening existing vulnerabilities, rather than creating a new problem from scratch.
However, the study authors are careful to state that these findings are not a final verdict. Because the research relied on women remembering and reporting their own experiences, it cannot prove that the hormones directly caused the improvements. It is possible that feeling better physically—sleeping more soundly or feeling less anxious—made it easier to focus, creating an indirect benefit. Furthermore, many women in the survey were taking multiple types of hormones at once, making it hard to isolate the effect of a single ingredient. The study also noted that the group of women who reported feeling better was not representative of every woman with ADHD, as the participants were recruited from online communities where people often share their struggles and solutions.
Despite these limitations, the survey offers a valuable glimpse into a largely unexplored area of women's health. It suggests that for many women, the type of hormone treatment they choose might influence how their attention and emotional regulation feel during midlife. The data points toward skin-applied estrogen and testosterone as the options most frequently associated with feeling sharper and more in control, while progesterone-based treatments showed less consistent results. This does not mean that hormone therapy is a cure for ADHD, nor does it prove that one treatment is superior to another for everyone. Instead, it highlights a strong signal that hormones and the brain are deeply connected in midlife, and that future research needs to look more closely at how specific treatments might help women manage these complex symptoms. The story here is one of hope and curiosity, inviting a deeper look at how balancing hormones might help restore a sense of mental clarity for women in the second half of life.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.